v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 3,000 $ 84,052,000 $ (69,107,000) $ 14,948,000
Balance (in Shares) at Dec. 31, 2024 3,474,970      
Common Stock issued to directors 39,000 39,000
Common Stock issued to directors (in Shares) 9,185      
Stock-Based Compensation 435,000 435,000
Common Stock issued for cash $ 1,000 854,000 855,000
Common Stock issued for cash (in Shares) 209,940      
Net Loss (988,000) (988,000)
Balance at Mar. 31, 2025 $ 4,000 85,380,000 (70,095,000) 15,289,000
Balance (in Shares) at Mar. 31, 2025 3,694,095      
Balance at Dec. 31, 2025 $ 5,000 89,608,000 (70,412,000) 19,201,000
Balance (in Shares) at Dec. 31, 2025 4,776,454      
Common Stock issued to directors 14,000 14,000
Common Stock issued to directors (in Shares) 4,600      
Stock-Based Compensation 950,000 950,000
Net Loss (1,020,000) (1,020,000)
Balance at Mar. 31, 2026 $ 5,000 $ 90,572,000 $ (71,432,000) $ 19,145,000
Balance (in Shares) at Mar. 31, 2026 4,781,054